ArticleFrontiers in cardiovascular medicine2026
Ultrasound in cardiovascular care: a perspective on preventive, diagnostic, and monitoring applications.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular disease (CVD) remains the leading global cause of death, underscoring the need for improved strategies for early detection and prevention. Conventional risk models such as Framingham and SCORE estimate population-level risk but often fail to identify individuals with subclinical vascular damage. Atherosclerosis, the underlying cause of most CVDs, develops silently for decades, emphasizing the importance of imaging modalities capable of detecting early vascular changes. Ultrasound offers a safe, non-invasive, and radiation-free means to visualize vascular structure, function, and hemodynamics in real time. This perspective reframes ultrasound as a cornerstone of preventive and diagnostic vasculature medicine in general, and cardiovascular medicine in particular, emphasizing major modalities-point-of-care ultrasonography (POCUS), Doppler, Duplex, contrast-enhanced ultrasound (CEUS), elastography, and pulse wave velocity (PWV). These techniques enable early risk stratification, monitoring of atherosclerotic progression, and evaluation of therapeutic response across carotid, aortic, peripheral, coronary, cerebral, and renal arteries. Ultrasound also serves as a behavioral catalyst, enhancing patient awareness and engagement. However, widespread adoption requires standardized protocols, provider training, ethical oversight, and equitable implementation to avoid global disparities. Recent advances in artificial intelligence (AI), machine learning (ML), and deep learning (DL) are revolutionizing ultrasound by automating plaque quantification, improving reproducibility, and expanding access through portable and handheld systems. Cloud-based interpretation and telemedicine integration further extend cardiovascular screening into community and home settings. As ultrasound evolves into a frontline technology for prevention, diagnosis, and monitoring, its integration with AI-driven interpretation and mobile health platforms positions it as a pivotal tool in personalized and equitable cardiovascular care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.